✦ LIBER ✦

Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?

✍ Scribed by Scillitani, A.; Mazziotti, G.; Somma, C.; Moretti, S.; Stigliano, A.; Pivonello, R.; Giustina, A.; Colao, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating Sclerostin Levels Are Decrea

✍ van Lierop, A. H.; van der Eerden, A. W.; Hamdy, N. A. T.; Hermus, A. R.; den He 📂 Article 📅 2012 🏛 Endocrine Society 🌐 English ⚖ 620 KB

Morphometric and densitometric evaluatio

✍ P. A. Soszynski; A. Kasperlik-Zaŀuska; L. Papierska; S. Zgliczyński 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 134 KB

Documenting Treatment Cure in Prostate C

✍ F.A. Vicini; C. Shah; L.L. Kestin; M. Ghilezan; D.J. Krauss; D. Brabbins; A.A. M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Evaluation of Baseline Cortisol, Endogen

✍ Burkhardt, W.A.; Boretti, F.S.; Reusch, C.E.; Sieber-Ruckstuhl, N.S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

BclI polymorphism of the glucocorticoid

✍ Ágnes Szappanos; Attila Patócs; Judit Tõke; Belema Boyle; Márta Sereg; Judit Maj 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Labetalol in the treatment of patients w

✍ RR Bailey 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB